Trending...
- Mintana Launches Chrome Extension to Simplify Memecoin Creation on Solana
- Colorado Springs: City to observe Memorial Day on Monday
- City Council invites community engagement: Volunteer for Colorado Springs Boards, Commissions, and Committees
The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports.
TEMECULA, Calif. - ColoradoDesk -- Jellyfish Publication-Certified Nutraceuticals, Inc.
Gerald M. Haase, M.D.
Clinical Professor of Surgery, University of Colorado School of Medicine, Aurora, CO.
Neil E. Wolkodoff, PhD
Medical Program Director, Colorado Center for Health and Sports Science, Denver, CO.
May 16, 2025
Certified Nutraceuticals, Inc., a research and product development enterprise in Pauma Valley, California, U.S.A., announces the publication of an exciting new human clinical trial of its proprietary KollaJell™ collagen peptide formulation.
The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports. The strength of this prospective, randomized trial is the distinctive utilization of a panel of brain function metrics from two robust, validated instruments, including a computerized neurocognitive test battery and an electroencephalographic (EEG) profile of voltage activation and wave phase pattern. Instead of evaluating only one or two parameters, this investigation assessed seven domains of cognitive function in 23 subjects who consumed KollaJell™ for a period of eight weeks.
More on Colorado Desk
The outcomes were clinically relevant, and all were statistically analyzed and achieved statistical significance. Standard scores matched for age and gender improved in all metrics regardless of the functional status of where the subject started. The parameters included compositive memory, neurocognitive index, visual memory, executive function and verbal memory. Under EEG monitoring conditions, the mean total reaction time and the trail-making composite test times also decreased dramatically. Topographic brain images showed voltage activation in the brain regions associated with sensory input and processing function. There were no adverse effects of consuming the supplement in any subject at any time during the study.
The importance of this pilot trial is the demonstration of a particularly extensive spectrum of beneficial results from the proprietary formulation compared to competing products that, even if helpful, provide only limited effects. In addition, the use of a marine-based natural collagen was superior to the usual animal-based products and the patented extraction process provided a greater platform of collagen types and a uniquely effective amino acid composition. This human clinical trial reinforces the concept that Certified Nutraceuticals KollaJell™ is a safe and beneficial collagen supplement that supports cognitive domains and memory and is applicable to a wide audience of potential consumers, regardless of their initial brain function status.
More on Colorado Desk
The actual medical study is available as a free open-access publication at https://www.auctoresonline.org/article/effects-of-a-jellyfish-collagen-based-amino-acid-supplement-on-cognitive-function-and-memory-a-pilot-investigation
For further information about the product or study, please contact:
Sara Alkayali at (951) 600-3899 or email: salkayali@certifiednutra.com
Gerald M. Haase, M.D.
Clinical Professor of Surgery, University of Colorado School of Medicine, Aurora, CO.
Neil E. Wolkodoff, PhD
Medical Program Director, Colorado Center for Health and Sports Science, Denver, CO.
May 16, 2025
Certified Nutraceuticals, Inc., a research and product development enterprise in Pauma Valley, California, U.S.A., announces the publication of an exciting new human clinical trial of its proprietary KollaJell™ collagen peptide formulation.
The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports. The strength of this prospective, randomized trial is the distinctive utilization of a panel of brain function metrics from two robust, validated instruments, including a computerized neurocognitive test battery and an electroencephalographic (EEG) profile of voltage activation and wave phase pattern. Instead of evaluating only one or two parameters, this investigation assessed seven domains of cognitive function in 23 subjects who consumed KollaJell™ for a period of eight weeks.
More on Colorado Desk
- This Artificial Intelligence Platform Could Change How Hollywood Gets Funded Forever
- Relief Mental Health Opens First Colorado Clinic in Denver, Expanding Access to Rapid, Innovative Care
- $100 Million Financing Unlocked for Aggressive Acquisition and Growth Strategy Including Plan to Acquire Remote Lottery Platform: Stock Symbol: LTRY
- ARCH Dental + Aesthetics Unveils New Website for Enhanced Patient Experience
- Plheart Announces Under $20 Body-Safe Pleasure Products
The outcomes were clinically relevant, and all were statistically analyzed and achieved statistical significance. Standard scores matched for age and gender improved in all metrics regardless of the functional status of where the subject started. The parameters included compositive memory, neurocognitive index, visual memory, executive function and verbal memory. Under EEG monitoring conditions, the mean total reaction time and the trail-making composite test times also decreased dramatically. Topographic brain images showed voltage activation in the brain regions associated with sensory input and processing function. There were no adverse effects of consuming the supplement in any subject at any time during the study.
The importance of this pilot trial is the demonstration of a particularly extensive spectrum of beneficial results from the proprietary formulation compared to competing products that, even if helpful, provide only limited effects. In addition, the use of a marine-based natural collagen was superior to the usual animal-based products and the patented extraction process provided a greater platform of collagen types and a uniquely effective amino acid composition. This human clinical trial reinforces the concept that Certified Nutraceuticals KollaJell™ is a safe and beneficial collagen supplement that supports cognitive domains and memory and is applicable to a wide audience of potential consumers, regardless of their initial brain function status.
More on Colorado Desk
- Governor Polis Signs Laws in Southern Colorado to Support Colorado Students, Invest in Low-Cost Geothermal Energy, Increase Health Care Access and Support Land Access
- Juventix Regenerative Medical Announces Strategic Partnership with Juvasonic® to Expand Needle-Free Biologic Delivery Platform
- Boulder SEO Marketing Opens Fort Collins Office to Serve Growing Northern Colorado Market
- Prymax Media & Technology Group Acquires 'Hidden Treasures' From Estate of Jewel Records Founder Stan Lewis
- Cooking with the Godfather Blends Family Tradition, Italian Flavor, and Leadership Wisdom
The actual medical study is available as a free open-access publication at https://www.auctoresonline.org/article/effects-of-a-jellyfish-collagen-based-amino-acid-supplement-on-cognitive-function-and-memory-a-pilot-investigation
For further information about the product or study, please contact:
Sara Alkayali at (951) 600-3899 or email: salkayali@certifiednutra.com
Source: Certified Nutraceuticals, Inc.
Filed Under: Health
0 Comments
Latest on Colorado Desk
- Colorado: Innovative Steamboat Springs Prosthetics Company Receives Award for Excellence in Exporting
- Governor Polis Signs Laws to Fully Fund Colorado Schools, Expand Resources for Students, and Foster a Stronger Workforce, Economy & Colorado for All, Takes Action on Bills
- Lt. Governor Dianne Primavera Joins Hundreds of Volunteers at PeriodPalooza, Helping Colorado Students Access Period Products
- The Great Reset, the First Photorealistic AI Film Makes History at the Cannes Film Festival
- Global Patient Organizations Applaud Historic Passage of Integrated Lung Health Resolution at World Health Assembly 78
- Love, Laughter, And Legacy Collide In The Romantic Comedy "different With Me"
- Natalie Jean Releases Heartfelt Tribute Single "What They Didn't See" Honoring Late Friend and Lyricist Michael Peloso
- LaPour Commemorates Completion of Centennial, Colorado's Newest Shallow Bay Industrial Facility with American Flag Raising Event with Vietnam Veterans of America (VVA) Chapter 1106
- Colorado: Governor Polis Signs Wage Theft Bill into Law to Ensure Fair Pay for Workers, Bills to Protect Wildlife and Pets
- City Council invites community engagement: Volunteer for Colorado Springs Boards, Commissions, and Committees
- Business Funding Assist Significantly Expands Funding Solutions, Empowering Businesses Across the U.S. and Canada
- Leadership Expert and Author Adam Holbrook Launches Breakthrough Book: Character Evolution
- City of Colorado Springs Opens Reservations for Trackchair Program
- Colorado: Under Cover of Darkness, House GOP Passes Cruel Bill to Slash Medicaid, Which Would Kick Coloradans Off Health Care, and Raise Costs
- Premium Domain Name "Feedri.com" Now Available for Acquisition After $8,500 Offer
- Headwaters Group Launches Aspendale Brand to Meet Growing Demand for Active 55+ Living
- Governor Polis Unveils Renderings for New Pedestrian Walkway Honoring Colorado's 150th Birthday
- Solomon Eye Appoints Dr. Nancy Draskovic as Clinical Director of Ocular Surface Disease
- 150% Increase in Fiscal Q2 Sales vs Previous Year to $750,000; Continuous Record Quarters & Profitability for Homebuilding Product: Innovative Designs
- Use Dogecoin (DOGE) to mine Bitcoin (BTC) and earn passive income at home